ArticleArchives of toxicology2026
Developmental neurotoxicity of thyroid hormone system-disrupting chemicals: a systems-level exploration using multi-omics approach.
Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is increasing concern that thyroid hormone system-disrupting chemicals (THSDCs) may affect brain development during gestation and lactation. THSDCs comprise a wide range of natural and synthetic xenobiotics that activate diverse biological pathways. However, how disruption of specific molecular targets alters maternal thyroid hormone homeostasis and brain development in the offspring warrants further investigation. To address this question, this study investigates the effects of two THSDCs administered to pregnant rats from gestational day 6 through postnatal day 21: 5-propyl-2-thiouracil (PTU, 2.4 mg/kg/day), inhibitor of thyroid hormone synthesis, and pregnenolone-16α-carbonitrile (PCN, 300 mg/kg/day), inducer of hepatic enzymes involved in thyroid hormone metabolism. Circulating and brain thyroid hormone levels, enzymatic activities, and histopathology were assessed in dams and offspring. To further elucidate underlying mechanisms, multi-omics analyses combining proteomics, metabolomics, and spatial transcriptomics were performed on target organs including the thyroid gland, liver, and brain. Exposure to PTU resulted in severe thyroid hormone depletion in both serum and brain, accompanied by structural brain abnormalities, whereas PCN primarily induced hepatic enzyme activity with minimal effect on circulating thyroid hormone levels. Despite these distinct modes of action, multi-omics integration revealed convergent perturbations across molecular layers in the brain, particularly affecting energy metabolism and cytoskeletal organization with more pronounced effects observed following PTU exposure. Overall, multi-omics profiling enabled robust and highly sensitive identification of molecular signatures reflective of PCN exposure, without significant evidence of associated adverse toxicological effects. This approach highlights the value of multi-omics for mechanistic characterization and predictive assessment of THSDC-induced neurodevelopmental toxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.